In vitro and in vivo multidrug resistance reversal activity by a Betti-base derivative of tylosin

British Journal of Cancer

Volumn 103, Issue 2, 2010, Pages 178-185

  Gyemant N ^a,b   Engi, H ^a,b   Schelz, Z ^a   Szatmari I ^c   Toth D ^c   Fulop F ^c   Molnar J ^a   De Witte, P A M ^b  

^a UNIVERSITY OF SZEGED   (Hungary)

^b UNIVERSITY OF LEUVEN   (Belgium)

^c UNIVERSITY OF SZEGED   (Hungary)

Author keywords

[No Author keywords available]

Indexed keywords

DOXORUBICIN; GLYCOPROTEIN P; MULTIDRUG RESISTANCE PROTEIN 1; N TYLOSIL 1 ALPHA AMINO (3 BROMOPHENYL) METHYL 2 NAPHTHOL; RHODAMINE 123; TYLOSIN DERIVATIVE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL CELL CULTURE; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CELL CULTURE; CANCER CHEMOTHERAPY; CANCER RESISTANCE; CYTOTOXICITY; DRUG BLOOD LEVEL; DRUG DISTRIBUTION; DRUG LIVER LEVEL; DRUG POTENTIATION; FEMALE; IN VITRO STUDY; IN VIVO STUDY; MOUSE; MULTIDRUG RESISTANCE; NONHUMAN; PRIORITY JOURNAL; T CELL LYMPHOMA; TISSUE DISTRIBUTION;

ANIMALS; CELL LINE, TUMOR; CELL PROLIFERATION; DOXORUBICIN; DRUG RESISTANCE, MULTIPLE; DRUG RESISTANCE, NEOPLASM; LACTONES; MICE; MICE, INBRED DBA; NAPHTHOLS; P-GLYCOPROTEIN; RHODAMINE 123; TRANSFECTION; TYLOSIN; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 77954656220     PISSN: 00070920     EISSN: 15321827     Source Type: Journal    
DOI: 10.1038/sj.bjc.6605716     Document Type: Article

References (0)